Biotest AG

BTTAY · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$26$127$32-$63
Dep. & Amort.$41$36$36$31
Deferred Tax$0$0-$1$0
Stock-Based Comp.$0$0$0$0
Change in WC-$0-$169-$45$22
Other Non-Cash-$6$3-$63$45
Operating Cash Flow$61-$3-$41$34
Investing Activities
PP&E Inv.-$29-$33-$29-$18
Net Acquisitions$0$35$0$0
Inv. Purchases$0$0-$8-$6
Inv. Sales/Matur.$0$0$0$5
Other Inv. Act.$3-$0$0-$5
Investing Cash Flow-$26$1-$37-$23
Financing Activities
Debt Repay.-$28-$2$100$25
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid-$2$0-$1-$1
Other Fin. Act.-$6-$5-$10-$2
Financing Cash Flow-$35-$7$90$23
Forex Effect-$0$0$0$0
Net Chg. in Cash-$0-$9$12$33
Supplemental Information
Beg. Cash$108$117$104$71
End Cash$108$108$117$104
Free Cash Flow$32-$36-$70$16
Biotest AG (BTTAY) Financial Statements & Key Stats | AlphaPilot